Marie-Eve Paquet completed her PhD in immunology in 2004 after working under the supervision of David Williams. Her research has focused on the molecular aspects of processing MHC class I antigen in emergency rooms and trafficking to the cell surface. She completed a post-doctoral training in Hidde Ploegh's lab at Harvard and the Whitehead Institute (MIT) where she used her expertise to develop genetically engineered mice to study the translocation processes of proteins from the ER to cytosol and explore the relationship between viruses and the immune system.
She then joined CERVO to create a viral vector platform focused on optogenetics. With her team, she now distributes quality vectors to more than 200 laboratories in 12 Canadian universities and 5 institutes as well as several other universities around the world. She is also a member of the executive board of the Canadian Science Platforms Network which was created to network, raise awareness, promote shared science platforms and influence their funding.